0002064189-25-000001.txt : 20250627 0002064189-25-000001.hdr.sgml : 20250627 20250627155809 ACCESSION NUMBER: 0002064189-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250627 DATE AS OF CHANGE: 20250627 EFFECTIVENESS DATE: 20250627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CB Equity Overage Fund XI, LP CENTRAL INDEX KEY: 0002064189 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-550206 FILM NUMBER: 251086079 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-619-5400 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0002064189 CB Equity Overage Fund XI, LP 200 CLARENDON STREET, 54TH FLOOR BOSTON MA MASSACHUSETTS 02116 617-619-5400 DELAWARE None None Limited Partnership true 2025 N/A N/A CB Equity Fund XI GP, LP 200 Clarendon Street, 54th Floor Boston MA MASSACHUSETTS 02116 Promoter General Partner ("GP") of the Issuer N/A N/A CB Equity Fund XI GP, LLC 200 Clarendon Street, 54th Floor Boston MA MASSACHUSETTS 02116 Promoter GP of the GP of the Issuer N/A N/A Charlesbank Capital Partners, LLC 200 Clarendon Street, 54th Floor Boston MA MASSACHUSETTS 02116 Promoter Sole Member of the GP of the GP of the Issuer Kevin Whelan c/o Charlesbank Capital Partners, LLC 200 Clarendon Street, 54th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Chief Financial Officer of the Sole Member of the GP of the GP of the Issuer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 Jefferies LLC 2347 None None 520 Madison Avenue New York NY NEW YORK 10022 All States true GrovePeak S.A.S. None None None Cr 5 # 116-58 T1 of601 Bogota, DC F8 COLOMBIA 110111 true Indefinite 0 Indefinite false 0 0 true 0 true Placement agent fees will be paid pursuant to a fee schedule based upon sales of interests to certain investors, and are disclosed in the Issuer's confidential offering materials. 0 true Certain affiliates of the GP may receive payments deemed to be made from offering proceeds including incentive allocations as disclosed in the Issuer's confidential offering materials, which cannot be estimated at this time. false CB Equity Overage Fund XI, LP Michael Treisman Michael Treisman MGNG DIR. GC and CCO of SOLE MBR of GP of GP of Issuer 2025-06-27